HMGB1 and idiopathic pulmonary fibrosis: HMGB-1 might have a crucial role in AE-IPF pathogenesis through its proinflammatory, thrombotic, and profibrotic function and may therefore be a biomarker of AE-IPF and a potential target for AE-IPF treatment.